Journals / Hacettepe Journal of Biology and Chemistry / 2014 / Cilt: 42 - Sayı: 3

PEG/Gelatin Composite Hydrogels as a Support of Enzyme Immobilization

Enzim İmmobilizasyonu için PEG/Jelatin Kompozit Hidrojeller

Pages
343–350
Publication Date
2014-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to these results composite hydrogels are thought to be adapted for different enzyme systems with the selection of the suitable ratio.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the recent years composite hydrogels have gained considerable interest as a biomaterial vehicle for biomedi- cal applications.
📊
Key Findings & Data:PEG/Gelatin composite hydrogels were prepared by mixing Polyethylene glycol diacrylate PEG 30% - 50% and Gelatin 22.000, 24.000, 40.000, 50.000, 87.500 MW in the precense of ethylene glycol di- methacrylate EGDMA as crosslinker and 2,2-dimethoxy-2-phenylacetophenone DMPA as photo initiator and also GOD 0.1 mg/ml for enzyme immobilization.
💡
Conclusion & Impact:According to these results composite hydrogels are thought to be adapted for different enzyme systems with the selection of the suitable ratio.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:PEG · Jelatin · Fotopolimerizasyon

Abstract

In the recent years composite hydrogels have gained considerable interest as a biomaterial vehicle for biomedi- cal applications. The purpose of this study is to prepare highly biocompatible Polyethylene glycol PEG /Gelatin composite hydrogels for Glucose Oxidase GOD immobilization and evaluate the enzyme activity. PEG/Gelatin composite hydrogels were prapered by one step simultaneous technique based on UV-initiated free radical pho- topolymerization. PEG/Gelatin composite hydrogels were prepared by mixing Polyethylene glycol diacrylate PEG 30% - 50% and Gelatin 22.000, 24.000, 40.000, 50.000, 87.500 MW in the precense of ethylene glycol di- methacrylate EGDMA as crosslinker and 2,2-dimethoxy-2-phenylacetophenone DMPA as photo initiator and also GOD 0.1 mg/ml for enzyme immobilization. Enzyme activity studies revealed that GOD immobilized PEG/Gelatin composite hydrogels that contain 30% PEG-DA presented a better activity, lower Km and higher Vmax than GOD immobilized composite hydogels that contain 50% PEG-DA. According to these results composite hydrogels are thought to be adapted for different enzyme systems with the selection of the suitable ratio.

Özet

Son yıllarda kompozit hidrojeller, biyomedikal uygulamalar için biyomalzeme aracı olarak önemli bir ilgi kazanmıştır. Bu çalışmanın amacı, glikoz oksidaz GOD immobilizasyonu ve enzim etkinliğini değerlendirmek için oldukça biyouyumlu polietilenglikol PEG /jelatin kompozit hidrojeller hazırlamaktır. PEG/jelatin kompozit hidrojeller UV başlatıcılı serbest radikal fotopolimerizasyon esasına dayalı tek basamaklı simultane tekniği ile hazırlandı. PEG/jelatin kompozit hidrojeller etilen glikol dimetakrilat EGDMA çapraz bağlayıcı maddesi, 2,2-dimetoksi-2-fenilasetofenon DMPA foto başlatıcısı ve enzim immobilizasyonu için glukoz oksidaz GOD 0.1 mg/ml varlığında %30 ve 50 polietilen glikol PEG ve jelatin 22.000, 24.000, 40.000, 50.000, 87.500 MW karıştırılarak hazırlanmıştır. Enzim aktivite çalışmaları, % 30 PEG içeren GOD immobilize PEG/jelatin kompozit hidrojellerin % 50 PEG içeren GOD immobilize PEG/jelatin kompozit hidrojellere göre daha iyi aktivite, düşük K ve daha yüksek Vsergilediğini göstermiştir. Bu sonuçlar, kompozit hidrojellerin uygun oranının seçimi ile farklı enzim sistemlerine adapte edilebileceğini düşündürmüştür. m max

🔖

Cite This Article

AYHAN, F., GÜLSU, A., AYHAN, H. (2014). PEG/Gelatin Composite Hydrogels as a Support of Enzyme Immobilization. Hacettepe Journal of Biology and Chemistry, Cilt: 42 - Sayı: 3, 343–350. https://ajindex.com/articles/256142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Sheldon, R.A., Enzyme immobilization: The quest for optimum performance, Synth. Catal., 35 (2007) 1289
  2. Krajewska, B., Application of chitin and chitosan based materials for enzyme immobilizations: A review, Enz. Microbial Technol., 35 (2004) 126
  3. Basri, M., Harun, A., Ahmad, M.B., Razak, C.N.A., Salleh, A.B., Immobilization of lipase on poly(N-vinyl2-pyrrolidoneco- styrene) hydrogel. DOI: 10.1002/app. 1977.J. Appl. Polym. Sci., 82 (2001) 1404
  4. Brahim, S., Narinesingh, D., Guiseppi-Elie, A., Kinetics of glucose oxidase immobilized in p(HEMA)-hydrogel microspheres in a packed-bed bioreactor. DOI: 10.1016/ S1381-1177(02)00061-9, J. Mol. Catal. B. Enzym., 18 (2002) 69
  5. Chauhan, G.S., Mahajan, S., Sddiqui, K.M., Gupta, R., Immobilization of lipase on hydrogels: structural aspects of polymeric matrices as determinants of enzyme activity in different physical environments, DOI: 10.1002/app. 20244. 92, J. Appl. Polym. Sci., 2004, 3135-3143
  6. Gao, D., Xu, H., Philbert, M.A., Kopelman, R., Ultrafine hydrogel nanoparticles: synthetic approach and therapeutic application in living cells, Angew Chem Int Ed., 46, 2007, 2224-2227
  7. Gasser, B., About composite materials and their use in bone surgery, Injury-Int J Care Injured, 31, 2000, 48- 53
  8. Satish, C.S., Satish, K.P., Shivakumar, H.G., Hydrogels as controlled drug delivery systems: synthesis, crosslinking, water and drug transport mechanism, Ind J Pharm Sci., 68, 2006, 133-40
  9. Hennink, W.E., Van Nostrum, C.F., Novel cross-linking methods to design hydrogels, Adv. Drug Delivery Rev., 54, 2002, 13-16
  10. Padmavathi, N.C., Chatterji, P.R., Structural characteristics and swelling behavior of poly(ethylene glycol) diacrylate hydrogels, Macromolecules, 29, 1996, 1976–1979
  11. Ratner, B.D., Biomaterials science: An introduction to materials in medicine, Amsterdam, Boston: Elsevier Academic Press. xii, 851 p. 2004
  12. Tessmar, J.K., Gopferich, A.M., Customized PEGderived copolymers for tissue-engineering applications, Macromol Biosci., 7 (1), 2007, 23–39
  13. Veronese, F.M., Mero, A., The impact of PEGylation on biological therapies, Bio Drugs., 22 (5), 2008, 315-329
  14. H.G.l, “United States Patent,” 4055554, 1977
  15. Sigma Technical Bulletin, No.510, Sigma Chemical CO., St. Louis, 1983
  16. Cruise, G.M., Scharp, D.S., Hubbell, J.A., Biomaterials 19, 1998, 1287-1294
  17. Russell, R.J., Axel, A.C., Shields, K. L., Pishko, M.V., Polymer 42, 2001, 4893-4901
  18. Demirel, G., Ozcetin, G., Sahin, F.